Ripples Advisory Pvt. Ltd. is a demanding research house with best stock trading strategies- Feel Free Subscribe now >> https://www.placementindia.com/job-recruiters/company-ripples-advisory or Call 09644405056
Shares of Cadila Healthcare soared over 2 per cent on the Bombay stock Exchange after the drug maker said that it has received the final approval from the USFDA to market Acyclovir for Injection USP in strengths of 500 mg/vial and 1000 mg/vial. Buoyed by the development, shares of drug maker gained as much as 2.48 per cent to hit intra-day high of Rs 542.00 apiece on the Bombay Stock Exchange.
The scrip was currently trading at Rs 538.50 against previous close price of Rs 528.85. In a similar fashion, stocks of company were trading 1.65 per cent higher at Rs 537.60 apiece on the National Stock Exchange. Meanwhile, the broader benchmark BSE Sensex was trading at 31,144.24, down 11.67 points or 0.04 per cent, at 11:25 hours.
No comments:
Post a Comment